[Skip to content]

Change colour Grey on white Black on yellow
Birmingham and Solihull Mental health NHS Foundation Trust
Better Together
.
Bookmark and Share

Our response to the Prime Minister’s pledge at the Global Dementia Legacy Event

Published: 19/06/2014

 

Birmingham and Solihull Mental Health NHS Foundation Trust welcomes today’s pledge by the Prime Minister David Cameron for a new drive to discover new drugs and treatment for dementia.

As a Trust we are committed to dementia research and improving care for people living with dementia in Birmingham and Solihull and beyond. 

We were involved in the development and launch of the Birmingham and Solihull dementia strategy 2014-17, which aims to deliver a better model of health and social care for people who have or may develop dementia.

Our Trust is also committed to dementia research and has been involved in almost all large, grant-funded dementia clinical trials conducted in the UK over the last 15 years. We were delighted that one of our Trust’s research nurses was awarded £200k by the Burdett Trust to develop and evaluate a dementia skills training for nursing staff in care homes.  We are also leading the National Institute for Health Research ENRICH project across the West Midlands, encouraging care homes to participate in NIHR research in dementia, as well as stroke and diabetes. In addition, Dr Peter Bentham is analysing data collected to evaluate the effectiveness of brain training on cognitive function in people with Alzheimer’s disease.

But more needs to be done.  Trust Chief Executive John Short said: “It is estimated that there are more than 16,000 people in Birmingham and Solihull with dementia and this is predicted to grow by 31 per cent in Solihull and 18 per cent in Birmingham by 2021.  In the light of this we support the call for earlier access to new drugs for patients, greater research collaboration and facilitating much high-levels of investment.”